Open menu
Paytm Money logo
Download App
Tata Mutual Fund

Tata India Pharma & HealthCare Fund Direct-Growth

NAV
returns change indicator
9.3753
as on 15 Jul 2019 08:25 PM
0.0368(0.39%)
Last Change
loaderloader
Investment Performance
would have given a returns of
110,871
star
121,647
star
91,925
star
95,368
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
4,631
Profit (absolute return)
4.63%
in the last
1m
3m
1y
3y
max
+1% Higher Returns
With Direct Plans on Paytm Money
Investment Returns
In the last 3 months
3.68%
In the last 6 months
1.03%
In the last 1 year
3.64%
In the last 3 years
4.63%
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk
Scheme Information
Tata India Pharma & HealthCare Fund Direct-Growth
Tata India Pharma & HealthCare Fund Direct-Growth
as of 15 Jul 2019 08:25 PM
165.61 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 0.25% if redeemed within 3 months
1.15%
Expense Ratio
Plan
Growth
1.48%
Cash Holding
Benchmark
NIFTY Pharma Total Return Index
Scheme Document
Benchmark
NIFTY Pharma Total Return Index
Exit Load
Exit load of 0.25% if redeemed within 3 months
Scheme Document
Sectors Holding in this Mutual Fund
as on 30 Jun 2019
Sort By
Healthcare
98.52%
163.16 Cr
Sectors Holding in this Mutual Fund
as on 30 Jun 2019
Sort By
Healthcare
98.52%
163.16 Cr
Companies Holding in this Mutual Fund
as on 30 Jun 2019
Sort By
Dr. Reddy's Laboratories Ltd.
11.47%
19.00 Cr
Sun Pharmaceutical Inds. Ltd.
11.28%
18.68 Cr
Lupin Ltd.
10.35%
17.14 Cr
Ipca Laboratories Ltd.
9.70%
16.06 Cr
Divi's Laboratories Ltd.
9.67%
16.01 Cr
Abbott India Ltd.
7.89%
13.07 Cr
Procter & Gamble Health Ltd.
6.45%
10.68 Cr
Apollo Hospitals Enterprise Ltd.
6.18%
10.23 Cr
Alembic Pharmaceuticals Ltd.
4.73%
7.83 Cr
Sanofi India Ltd.
4.26%
7.06 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 30 Jun 2019
Sort By
Dr. Reddy's Laboratories Ltd.
11.47%
19.00 Cr
Sun Pharmaceutical Inds. Ltd.
11.28%
18.68 Cr
Lupin Ltd.
10.35%
17.14 Cr
Ipca Laboratories Ltd.
9.70%
16.06 Cr
Divi's Laboratories Ltd.
9.67%
16.01 Cr
Abbott India Ltd.
7.89%
13.07 Cr
Procter & Gamble Health Ltd.
6.45%
10.68 Cr
Apollo Hospitals Enterprise Ltd.
6.18%
10.23 Cr
Alembic Pharmaceuticals Ltd.
4.73%
7.83 Cr
Sanofi India Ltd.
4.26%
7.06 Cr
View All
View All
About Tata India Pharma & HealthCare Fund Direct-Growth
Tata India Pharma & HealthCare Fund Direct-Growth is a Equity mutual fund scheme from Tata Mutual Fund. This scheme was launched on 28 Dec 2015 and is currently managed by its fund managers Sailesh Jain and Meeta Shetty. It has an AUM of ₹165.61 Crores and the latest NAV decalared is ₹9.375 as on 15 Jul 2019 at 8:25 pm.
Tata India Pharma & HealthCare Fund Direct-Growth scheme return performance in last 1 year is 3.64%, in last 3 years is -4.63% and -6.57% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
AMC Information
Tata Mutual Fund
Tata Mutual Fund
View AMC Details
49,583.08 Cr
AUM
96
Schemes
Address
Address
9th Floor, Mafatlal Centre,Nariman Point,400021
Phone Number
Phone Number
Phone : 1800 209 0101